BIOAMBER INC. (NYSE:BIOA) Files An 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingItem 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On February15, 2018, BioAmber Inc. (the “Company”) received a letter from the Toronto Stock Exchange (the “TSX”) notifying the Company that it had determined to suspend trading of the Company’s shares of common stock, effective February16, 2018, and to delist the Company’s securities effective at the close of market on March16, 2018. The delisting was imposed for failure by the Company to meet the continued listing requirements of the TSX relating to compliance with listing agreements (s. 712(C)) and management deficiencies (s. 716).
The Company does not intend to appeal the TSX’s decision to delist its shares of common stock.
Item 3.01 Regulation FD Disclosure.
On February16, 2018, the Company issued a press release announcing the notice of suspension and delisting by the TSX. Acopy of the press release is included as Exhibit 99.1 to this report and is incorporated herein by reference.
The information contained in this Item 3.01, including Exhibit 99.1, is being “furnished” and shall not be deemed “filed” for purposes of Section18 of the Exchange Act or otherwise subject to the liability of that section or Sections 11 and 12(a)(2) of the Securities Act. The information in this Item 3.01, including Exhibit 99.1, shall not be incorporated by reference into any registration statement or other document to the Securities Act or into any filing or other document to the Exchange Act, except as otherwise expressly stated in any such filing.
This report shall not constitute an offer to sell, or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
Item 3.01 Financial Statements and Exhibits
(d) Exhibits
|
Exhibit Number |
Description |
| 99.1 | Press Release, dated February16, 2018. |
EXHIBIT INDEX
|
Exhibit Number |
Description |
| 99.1 | Press Release, dated February16, 2018. |
BioAmber Inc. ExhibitEX-99.1 2 d541046dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 BioAmber Inc. Receives Notice of Delisting by TSX Montreal,…To view the full exhibit click here
About BIOAMBER INC. (NYSE:BIOA)
BioAmber Inc. (BioAmber), formerly DNP Green Technology, Inc., is an industrial biotechnology company, which produces sustainable chemicals. The Company’s technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals, which are used in a range of everyday products, including plastics, food additives and personal care products. Its geographical segments include Europe and North America. Its product pipeline includes the derivatives of bio-succinic acid, such as 1,4 Butanediol (1,4 BDO) and tetrahydrofuran (THF), and succinic acid-based polyesters, and C6 building block chemicals, such as adipic acid, caprolactam and hexamethylenediamine (HMDA). Its products are used in various applications, including polyurethanes, resins and coatings, de-icing and coolant solutions, fine chemicals, lubricants, carpets, engineering plastics and artificial leather products.
